Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-{2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-1,4-benzothiazin-4-yl]ethyl}acetamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the benzothiazine class of organic compounds. Its structure features a fused benzene and thiazine ring system with an ethyl-substituted diamino-pyrimidine moiety. It is listed as an experimental pharmaceutical in chemical databases but does not have any approved medical indications or established clinical use. The compound has been referenced in cheminformatics and structural biology resources (e.g., as ligand "1IG" in protein structures), but there is no publicly available information on its mechanism of action or therapeutic application[1][6].
- Other names
- N-{2-[6-(24-diamino–6-Ethylpyrimidin5-Yl)22dimethyl30xo23dihydro41h14benzothiazin41yL]Ethyl}AcetamideN-{24diamino61ethYlpYrimiDin51Yl221DimethYl31oXo231DihYDro411414BenzothiAzin411YL]EthYl}AcetamiDe
Beyond the preview
Go deeper on N-{2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-1,4-benzothiazin-4-yl]ethyl}acetamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-{2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-1,4-benzothiazin-4-yl]ethyl}acetamide.